-
5-α reductase inhibitors and hip fracture in men; the effects of drug-reimbursement policy on outcomes; new guidelines for type 2 diabetes; beta-blocker-associated brady-cardia is linked to CVD events; FDA Updates.
-
-
Low PSA levels do not assure the absence of prostate cancer.
-
Recent studies have suggested that multiple myeloma and monoclonal gammopathy of unknown significance (MGUS) may predispose to venous thromboembolism, even in untreated patients.
-
In a retrospective review of hematopoietic stem cell transplantation for pre-treated patients with chronic lymphocytic leukemia, who have 17p deletion, three-year overall and progression-free survival were 44% and 37%, respectively. This matches favorably when compared to patients with the same chromosomal abnormality treated with chemotherapy alone.
-
-
The National Institute of Standards and Technology (NIST) released publication SP 800-66 Revision 1, An Introductory Resource Guide for Implementing the Health Insurance Portability and Accountability Act Security Rule, on Oct. 24.
-
Advances in information technology (IT) can improve the quality and other aspects of health care, but electronic storage and exchange of personal health information might compromise privacy, the Government Accountability Office (GAO) said in a report issued Sept. 17.
-
Several resources are available to health care providers and consumers on end-of-life issues.
-
The use of integrative medicine therapies continues to grow, with hospitals opening integrative medicine centers and health care providers offering massage therapy and acupuncture.